Molbio Diagnostics Clarifies Share Trading Volume Surge Is Purely Market-Driven
Molbio Diagnostics Ltd 路 Others (Uncategorized) 路 19 Oct 2026, 7:53 pm
Molbio Diagnostics Clarifies Share Trading Volume Surge Is Purely Market-Driven Molbio Diagnostics responded to BSE's query on 19th Oct'26 regarding a significant surge in trading volumes across stock exchanges. The company clarified that the volume movement is purely market-driven, confirming full compliance with Regulation 30 of SEBI (LODR) Regulations, 2015. Management affirmed that no undisclosed events, price-sensitive information, or announcements remain pending for regulatory submission.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company 路 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
